Betschel, Stephen D.
116  results:
?
2

A Core Outcome Set for Efficacy of Acute Treatment of Hered..:

Petersen, Remy S. ; Fijen, Lauré M. ; Apfelbacher, Christian...
The Journal of Allergy and Clinical Immunology: In Practice.  12 (2024)  6 - p. 1614-1621 , 2024
 
?
3

Long-Term Effectiveness and Safety of Lanadelumab in Patien..:

Bernstein, Jonathan ; Betschel, Stephen ; Busse, Paula...
Journal of Allergy and Clinical Immunology.  153 (2024)  2 - p. AB242 , 2024
 
?
5

Characterizing the HAE Patient Perspective on First-Line Pr..:

Betschel, Stephen ; Radojicic, Cristine ; van Kooten, Sally...
Journal of Allergy and Clinical Immunology.  153 (2024)  2 - p. AB86 , 2024
 
?
6

Definition, acronyms, nomenclature, and classification of a..:

Reshef, Avner ; Buttgereit, Thomas ; Betschel, Stephen D....
Journal of Allergy and Clinical Immunology.  154 (2024)  2 - p. 398-411.e1 , 2024
 
?
 
?
8

Effectiveness, Safety, and Patient-Reported Outcomes (PROs)..:

Wedner, H. James ; Bernstein, Jonathan ; Betschel, Stephen...
Journal of Allergy and Clinical Immunology.  151 (2023)  2 - p. AB131 , 2023
 
?
12

Second-dose mRNA COVID-19 vaccine safety in patients with i..:

Iaboni, Aled ; Jindal, Nina ; Betschel, Stephen D..
Journal of Allergy and Clinical Immunology: Global.  1 (2022)  3 - p. 172-174 , 2022
 
?
15

Impact of lanadelumab on patient-reported outcomes in hered..:

Busse, Paula ; Zaragoza-Urdaz, Rafael ; Betschel, Stephen...
Journal of Allergy and Clinical Immunology.  149 (2022)  2 - p. AB166 , 2022
 
1-15